Skip to content
About
Supporter
Expert Index
Editorial Board
Editorial Team
Editorial Policy
Contact
Sign up
Visit
Home
(current)
Specialties
Hematology
Oncology
Musculoskeletal Disorder
Rare Disease
Metabolic Disorder
Cardiovascular Disease
Ophthalmology
Neurology
Infectious Disease
View all Specialties
Technologies
Cell Therapy
MSC
iPSC
Gene Therapy
Genome Editing
Extracellular Vesicles
CAR-T Therapy
TCR Therapy
Tissue-Engineering & Biomaterials
View all Technologies
Topics
Treatment
Immuno-Oncology
Trial Updates
Perspectives
Manufacturing
COVID-19
View all Topics
Conferences
ASH 2022
TCT 2022
Meeting on the Med 2022
ICLE 2022
Advanced Therapies Week 2022
TERMIS 2021
ESGCT 2021
Meeting on the Mesa 2021
Advanced Therapies 2021
View all Conferences
About
Supporter
Expert Index
Editorial Board
Editorial Team
Editorial Policy
Contact
Sign up
Metabolic Disorder
1:58
Treating Krabbe disease with FBX-101
John Maslowski
• 27 Jan 2022
6:19
LYS-GM101 AAV gene therapy for GM1 gangliosidosis
Michael Hocquemiller
• 15 Nov 2021
3:42
GNT0003: AAV gene therapy for Crigler-Najjar syndrome
Lorenzo D'Antiga
• 18 Nov 2021
4:31
The safety of AVR-RD-01 gene therapy for Fabry disease
Mark Thomas
• 29 Oct 2021
2:31
The unmet medical need for Crigler-Najjar syndrome
Lorenzo D'Antiga
• 18 Nov 2021
2:38
LYS-SAF302 AAV gene therapy for MPS IIIA
Michael Hocquemiller
• 15 Nov 2021
1:16
Overcoming immunogenicity of gene therapies
Timothy Miller
• 18 Nov 2021
0:59
RESKUE: AAV-based gene therapy for Krabbe disease
Timothy Miller
• 18 Nov 2021
2:07
Treating Krabbe disease with AAV-based gene therapies
Timothy Miller
• 18 Nov 2021
3:22
The role of regenerative medicine in treating diabetes
Lorenzo Piemonti
• 11 Nov 2021
4:31
The future of regenerative medicine in transplantation
Giuseppe Orlando
• 11 Nov 2021
4:36
Bio-engineering vascularized islet organs for T1D
Lorenzo Piemonti
• 11 Nov 2021
3:34
Challenges in β cell replacement therapy
Lorenzo Piemonti
• 11 Nov 2021
1:57
Tailored nucleases for primary hyperoxaluria
Devyn Smith
• 29 Oct 2021
2:34
Advanced cell selection for the manufacture of ProTrans cell therapy
Mathias Svahn
• 6 Oct 2021
1:11
The benefits of umbilical cord-derived MSCs as a cell source
Mathias Svahn
• 6 Oct 2021
1
2
Next
